RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (8.29-8.32)]
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (8.29-8.32)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-WHO-TRS-986-8.29-8.32-768x1086.jpg)
Risk-Based Inspection (RBI) means planning frequency, depth and scope of GMP inspections based on patient/product risk, so high-risk systems get more time and tighter sampling of evidence. A well-known RBI model notes that a risk-based approach helps determine the frequency,…





![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (8.25-8.28)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-WHO-TRS-986-8.25-8.28-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.21-8.24)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.21-8.24-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.18-8.20)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.18-8.20-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.16-8.17)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.16-8.17-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.13-8.15)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.13-8.15-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.10-8.12)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.10-8.12-1-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.9)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.9-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.8)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.8-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.7)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.7-768x1086.jpg)

